Jinxin Fertility Group Limited's (HKG:1951) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jinxin Fertility Group Limited's (HKG:1951) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jinxin Fertility Group (HKG:1951) has had a great run on the share market with its stock up by a significant 8.6% over the last week. However, we decided to pay attention to the company's fundamentals which don't appear to give a clear sign about the company's financial health. In this article, we decided to focus on Jinxin Fertility Group's ROE.
金信生育集团（HKG：1951）在股市上表现良好，其股票比上周大幅上涨8.6％。但是，我们决定关注公司的基本面，这些基本面似乎并未给出公司财务状况的明确信号。在本文中，我们决定重点关注金信生育集团的投资回报率。
ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Put another way, it reveals the company's success at turning shareholder investments into profits.
投资回报率或股本回报率是评估公司如何有效地从股东那里获得投资回报的有用工具。换句话说，它揭示了公司成功地将股东投资转化为利润。
See our latest analysis for Jinxin Fertility Group
查看我们对金欣生育集团的最新分析
How Do You Calculate Return On Equity?
你如何计算股本回报率？
Return on equity can be calculated by using the formula:
股本回报率可以通过使用以下公式计算：
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
股本回报率 = 净利润（来自持续经营业务）÷ 股东权益
So, based on the above formula, the ROE for Jinxin Fertility Group is:
因此，根据上述公式，金欣生育集团的投资回报率为：
1.5% = CN¥154m ÷ CN¥10b (Based on the trailing twelve months to June 2023).
1.5% = 1.54亿元人民币 ¥10亿元人民币（基于截至2023年6月的过去十二个月）。
The 'return' is the yearly profit. That means that for every HK$1 worth of shareholders' equity, the company generated HK$0.02 in profit.
“回报” 是每年的利润。这意味着，每获得价值1港元的股东权益，公司就会产生0.02港元的利润。
What Has ROE Got To Do With Earnings Growth?
投资回报率与收益增长有什么关系？
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.
我们已经确定，投资回报率是衡量公司未来收益的有效盈利指标。然后，我们能够评估公司的收益增长潜力，具体取决于公司对这些利润进行再投资或 “保留” 了多少及其有效性。假设其他一切保持不变，那么与不一定具有这些特征的公司相比，投资回报率和利润保留率越高，公司的增长率就越高。
Jinxin Fertility Group's Earnings Growth And 1.5% ROE
金信生育集团的收益增长和1.5％的投资回报率
It is quite clear that Jinxin Fertility Group's ROE is rather low. Not just that, even compared to the industry average of 9.6%, the company's ROE is entirely unremarkable. Given the circumstances, the significant decline in net income by 6.5% seen by Jinxin Fertility Group over the last five years is not surprising. We reckon that there could also be other factors at play here. For example, the business has allocated capital poorly, or that the company has a very high payout ratio.
很明显，金信生育集团的投资回报率相当低。不仅如此，即使与9.6％的行业平均水平相比，该公司的投资回报率也完全不起眼。在这种情况下，金信生育集团在过去五年中净收入大幅下降6.5％也就不足为奇了。我们认为，这里可能还有其他因素在起作用。例如，企业的资本配置不佳，或者公司的支付率非常高。
However, when we compared Jinxin Fertility Group's growth with the industry we found that while the company's earnings have been shrinking, the industry has seen an earnings growth of 13% in the same period. This is quite worrisome.
但是，当我们将金信生育集团的增长与行业的增长进行比较时，我们发现，尽管该公司的收益一直在萎缩，但同期该行业的收益却增长了13％。这非常令人担忧。
Earnings growth is an important metric to consider when valuing a stock. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about Jinxin Fertility Group's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.
收益增长是估值股票时要考虑的重要指标。对于投资者来说，重要的是要知道市场是否影响了公司的预期收益增长（或下降）。通过这样做，他们将知道这只股票是进入清澈的蓝色海水还是沼泽水域在等着你。如果你想知道金信生育集团的估值，可以看看这个衡量其市盈率与行业比较的指标。
Is Jinxin Fertility Group Making Efficient Use Of Its Profits?
金欣生育集团是否正在有效利用其利润？
While the company did payout a portion of its dividend in the past, it currently doesn't pay a dividend. This implies that potentially all of its profits are being reinvested in the business.
尽管该公司过去确实支付了部分股息，但目前不支付股息。这意味着其所有利润都可能被再投资于该业务。
Summary
摘要
In total, we're a bit ambivalent about Jinxin Fertility Group's performance. Even though it appears to be retaining most of its profits, given the low ROE, investors may not be benefitting from all that reinvestment after all. The low earnings growth suggests our theory correct. That being so, the latest industry analyst forecasts show that the analysts are expecting to see a huge improvement in the company's earnings growth rate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.
总的来说，我们对金信生育集团的表现有些矛盾。尽管它似乎保留了大部分利润，但鉴于投资回报率低，投资者毕竟可能无法从所有这些再投资中受益。低收益增长表明我们的理论是正确的。尽管如此，最新的行业分析师预测显示，分析师预计该公司的收益增长率将大幅提高。要了解有关公司未来收益增长预测的更多信息，请看这个 免费的 报告分析师对公司的预测，以了解更多信息。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗？担心内容吗？ 取得联系 直接和我们在一起。 或者，给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。 我们仅使用公正的方法根据历史数据和分析师的预测提供评论，我们的文章无意作为财务建议。 它不构成买入或卖出任何股票的建议，也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意，我们的分析可能不考虑最新的价格敏感公司公告或定性材料。简而言之，华尔街在上述任何股票中都没有头寸。